lactic acid has been researched along with Neuroendocrine Tumors in 4 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Neuroendocrine Tumors: Tumors whose cells possess secretory granules and originate from the neuroectoderm, i.e., the cells of the ectoblast or epiblast that program the neuroendocrine system. Common properties across most neuroendocrine tumors include ectopic hormone production (often via APUD CELLS), the presence of tumor-associated antigens, and isozyme composition.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Of the 20 patients, 17 patients had carcinoid tumors and three had islet cell tumors." | 2.69 | Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. ( Ajani, JA; Brown, CA; Carrasco, HC; Chuang, VP; Diamandidou, E; Lawrence, DD; Wallace, S; Yang, DJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, E | 1 |
| Miéville, P | 1 |
| Warren, CM | 1 |
| Saghafinia, S | 1 |
| Li, L | 1 |
| Peng, MW | 1 |
| Hanahan, D | 1 |
| Ghassemi, AH | 1 |
| van Steenbergen, MJ | 1 |
| Barendregt, A | 1 |
| Talsma, H | 1 |
| Kok, RJ | 1 |
| van Nostrum, CF | 1 |
| Crommelin, DJ | 1 |
| Hennink, WE | 1 |
| Arora, G | 1 |
| Shukla, J | 1 |
| Ghosh, S | 1 |
| Maulik, SK | 1 |
| Malhotra, A | 1 |
| Bandopadhyaya, G | 1 |
| Diamandidou, E | 1 |
| Ajani, JA | 1 |
| Yang, DJ | 1 |
| Chuang, VP | 1 |
| Brown, CA | 1 |
| Carrasco, HC | 1 |
| Lawrence, DD | 1 |
| Wallace, S | 1 |
1 trial available for lactic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors.
Topics: Adenoma, Islet Cell; Antineoplastic Agents; Capsules; Carcinoid Tumor; Chemoembolization, Therapeuti | 1998 |
3 other studies available for lactic acid and Neuroendocrine Tumors
| Article | Year |
|---|---|
Metabolic Symbiosis Enables Adaptive Resistance to Anti-angiogenic Therapy that Is Dependent on mTOR Signaling.
Topics: Angiogenesis Inhibitors; Animals; Axitinib; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expres | 2016 |
Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
Topics: Acromegaly; Acylation; Antineoplastic Agents, Hormonal; Delayed-Action Preparations; Drug Carriers; | 2012 |
PLGA nanoparticles for peptide receptor radionuclide therapy of neuroendocrine tumors: a novel approach towards reduction of renal radiation dose.
Topics: Animals; Kidney; Lactic Acid; Nanoparticles; Neuroendocrine Tumors; Octreotide; Organometallic Compo | 2012 |